TSW
SRTS icon

Thompson Siegel & Walmsley’s Sensus Healthcare SRTS Stock Holding History

Thompson Siegel & Walmsley’s Portfolio SRTS Stock Details SRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,177
Closed -$128K – 571
2022
Q3 		$128K Buy
+10,177
New +$122K ﹤0.01% 372

Other funds holding SRTS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
NA
Navellier & Associates Reno, Nevada $960M AUM 79.37% 1-Year Est. Return

Thompson Siegel & Walmsley's SRTS Position: Q4 2022 in Review

Thompson Siegel & Walmsley sold out of Sensus Healthcare (SRTS) in Q4 2022, closing a stake of 10,177 shares — an estimated $128K sold.

Thompson Siegel & Walmsley first reported a position in SRTS in Q3 2022 and held it in 1 quarter. The position peaked at $128K in Q3 2022. 67 funds tracked by Wall St. Rank hold SRTS as of Q4 2022.

  • Thompson Siegel & Walmsley reported no remaining Sensus Healthcare position as of Q4 2022 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 10,177 Sensus Healthcare shares in Q4 2022, an estimated $128K.
  • Thompson Siegel & Walmsley first reported a position in Sensus Healthcare in Q3 2022 and held it in 1 quarter.
  • Thompson Siegel & Walmsley's Sensus Healthcare position peaked at $128K in Q3 2022.
  • 67 funds tracked by Wall St. Rank held Sensus Healthcare as of Q4 2022.

Based on Thompson Siegel & Walmsley's 13F filing for Q4 2022, filed 10 Feb 2023.